newsfilter
← Latest News
GlobeNewswire·

BeyondSpring Reports 2025 Year-End Financial Results

Plinabulin (BeyondSpring's Lead Program): Phase 3 Survival Benefit Confirmed: Plinabulin combined with docetaxel demonstrated statistically significant overall survival benefit vs. standard of care docetaxel in EGFR